- Source: Tolvaptan phosphate
Tolvaptan phosphate is a drug used for the treatment of cardiac edema. It is a prodrug of tolvaptan, formulated as the salt tolvaptan sodium phosphate, for intravenous administration. Tolvaptan phosphate is converted into the active drug tolvaptan in the human body following administration.
It was developed by Otsuka Pharmaceutical Co. and was approved for use in Japan in 2022.
References
Kata Kunci Pencarian:
- Tolvaptan
- Tolvaptan phosphate
- Autosomal dominant polycystic kidney disease
- Vasopressin receptor
- Vasopressin receptor 2
- Lithium carbonate
- Ketoconazole
- Lithium (medication)
- Carbetocin
- Vasopressin receptor 1B
